Product Wiki · Recalls · EU Safety Gate (RAPEX)

Progarden — Furniture — recall A12/0052/13

EU Safety Gate (RAPEX) · Hungary · 2013-01-18 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/0052/13
Date of alert
2013-01-18
Country / jurisdiction
Hungary
Risk level
Serious risk
Risk type
Injuries
Brand
Progarden
Product category
Furniture
Product type
Plastic chair
Reported risk: A termék sérülésveszélyt jelent, mert a kartámasz helyzetének beállításakor nyírópont képződik, és a felhasználó keze és ujjai beszorulhatnak és megsérülhetnek. Ezenkívül a szék lábainak alja nyitott, ami összecsukáskor beszorulást és sérülést okozhat. A termék nem felel meg a vonatkozó EN 581-1 európai szabványnak.
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Risk Description (original English): The product poses a risk of injuries because, when adjusting the position of the armrest, a shear point is formed and the hands and fingers of the user can be entrapped and injured.In addition, the bottom of the chair legs is open, which could cause entrapment and injury when folding.The product does not comply with the relevant European standard EN 581-1.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/57494

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.